Tg(CAG-STC2)L314Gdm
Transgene Detail
|
|
| Symbol: |
Tg(CAG-STC2)L314Gdm |
| Name: |
transgene insertion L314, Gabriel E DiMattia |
| MGI ID: |
MGI:3626089 |
| Synonyms: |
Tg(ACTB-STC2)L314Gdm, Tg(CAG-STC2)L314Gdm |
| Transgene: |
Tg(CAG-STC2)L314Gdm Location: unknown
|
| Alliance: |
Tg(CAG-STC2)L314Gdm page
|
|
| Strain of Origin: |
C57BL/6 x CBA
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(CAG-STC2)L314Gdm expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
STC2 (8614) |
|
|
|
| |
|
Mutation details: A promoter consisting of the cytomegalovirus IE enhancer fused to the chicken beta-actin promoter together with 5'UTR sequence and intron 1 of the chicken beta-actin was used to drive a 1247 bp human cDNA followed by the rabbit globin 3'UTR. Two independent lines were produced, L314 and L372.
(J:96043)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:96043 Gagliardi AD, et al., Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E92-105 |
| All: |
1 reference(s) |
|